Mirco Dilda

HgCapital LLP (HgCapital) is a private equity firm founded in 1985 by Craig M. Donaldson. The firm is headquartered in London, United Kingdom with additional offices in Munich, Paris, New York and San Francisco.

Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom.

Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands.

Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA.

Argos Wityu SA (Argos Wityu) is an independent private equity firm founded in 1989. The firm is headquartered in Geneva, Switzerland.

Bellco SRL provides therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure. It offers haemodiafiltration therapies, dialysis machines equipment, haemodialysers, blood lines, catheters, concentrates, and sorbent cartridges; pathologies for acute patients; and altered haemodynamics, renal hypoperfusion, and low cardiac output therapeutic system for neonatal patients. The company was founded in 1972 and is headquartered in Mirandola, Italy.^

Altaris Capital Partners LLC (Altaris Capital Partners) is a private equity firm founded by George Aitken-Davies and Daniel Tully in 2003. The firm is headquartered in New York.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.

Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.

Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland.

Doubleday Acquisitions LLC manufactures and supplies thermal management products. The company was founded by Keith Meyer on April 20, 2004 and is headquartered in Dayton, OH.

Part of Edwards Lifesciences Corp., Edwards Lifesciences LLC develops and manufactures heart valves and hemodynamic monitoring systems. The company is based in Irvine, CA. The company was founded in 1958. Michael A. Mussallem has been the CEO of the company since 2000.

CMP Pharma, Inc. engages in the manufacture and distribution of prescription and non-prescription pharmaceutical products. Its products include Oracit, Dermacloud Ointment, Absorbase, Triamcinolone Acetonide, and Hydrocortisone HCl. The company was founded by Henry Lewis Smith in 1975 and is headquartered in Farmville, NC.

Mundipharma Pharmaceuticals SRL manufactures and supplies therapeutic remedies. It offers treatments in the respiratory, inflammatory, oncohematology, and pain therapy medical fields. The company was founded in 2005 and is headquartered in Milan, Italy.

BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland.

Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland.

Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors.

Chemical Computing Group ULC provides drug discovery software applications. It offers structure-based design, fragment-based design, Pharmacophore discovery, medicinal chemistry applications, biologics applications, protein and antibody modeling, molecular modeling and simulations, cheminformatics and QSAR and methods development and deployment. The firm's business activities encompass software research and development; worldwide sales, marketing, and support; and collaborative projects. It serves the pharmaceutical, biotechnology, and academic sectors. The company was founded in 1994 and is headquartered in Montreal, Canada.

Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland.

Medpass International SAS engages in medical device CRO, clinical research, regulatory, and reimbursement consultancy and development . It offers Strategic Consulting, EU Reimbursement, Regulatory Affairs, Clinical Operations, Biometrics, Authorized Representative, and Legal Representative and DPR. The company was founded by Sarah Sorrel in 1991 and is headquartered in Paris, France.

PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland.

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark.

Essential Pharma Ltd. engages in the manufacturing of pharmaceutical products. The company was founded on February 02, 2011 and is headquartered in Egham, the United Kingdom.

Part of Intas Pharmaceuticals Ltd., Essential Pharmaceuticals LLC is a company that manufactures and markets pharmaceutical products. The company is based in Durham, NC. The company was founded in 2006. Emma Jane Johnson has been the CEO of the company since 2023. Essential Pharmaceuticals was acquired by Accord Healthcare, Inc. on July 26, 2017.

Essential Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was founded on November 24, 2010 and is headquartered in Egham, the United Kingdom.

DSS Sustainable Solutions Switzerland SA engages in the provision of management consulting services. It offers safety and operational risk management, safety technologies, and learning and development. The company is headquartered in Wilmington, DE.

T-Heart SAS is an investment holding company with interest in research and development services on natural sciences sector. The company was founded on December 06, 2018 and is headquartered in Paris, France.

Engenome Srl develops software technology for the analysis and interpretation of molecular data in order to support translational research & clinical practice. The company was founded by Ettore Rizzo and Ivan Limongelli in 2016 and is headquartered in Pavia, Italy.

Sorin Group SpA is an Italian medical device company. The private company is based in Milan, Italy.

Rebio Technologies Ltd. operates as a biotechnology company. It provides medical products. The company was founded in January 14, 2014 and is headquartered in Cranleigh, the United Kingdom.

Evolve Healthcare Partners (Evolve Healthcare Partner) is a private equity firm founded in 2018 by Jordi Sabé and Mayer Ferdinand. The firm is headquartered in Barcelona London.

Takeda Digital Ventures (Takeda Digital Ventures) is a venture capital subsidiary of Takeda Pharmaceutical Co., Ltd. founded in 2018. The firm is headquartered in Cambridge, Massachusetts.